Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease
Clinical and Translational Science · 2026-11 · 19 (11)
DOI: 10.1111/cts.70782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 17.11.2026. Verfasst von Philippe Pinton. Beteiligte Einrichtung: Shiroito Co., Ltd., Health & Life Sciences, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Interleukin-6, Recombinant Fusion Proteins, Biological Products. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This Perspective examines why a subcutaneous version of olamkicept, a selective inhibitor of interleukin‐6 trans‐signaling, is still difficult to build from a full‐length Fc fusion. Using published pharmacokinetic data, a transparent dose calculation shows that clearance, not target abundance, sets the dose, and that half‐life is the most sensitive lever. Compact engineered formats are considered as design hypotheses, with working parameters for binding, volume, and viscosity. Four open questions are proposed before such formats advance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiroito Co., Ltd., Health & Life Sciences, Minato-ku, Tokyo, Japan.
ORCID-Profile: Philippe Pinton
Zitieren
APA
Pinton, P. (2026). Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease. Clinical and Translational Science, 19(11). https://doi.org/10.1111/cts.70782
Vancouver
Pinton P. Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease. Clinical and Translational Science. 2026;19(11). doi:10.1111/cts.70782
BibTeX
@article{Pinton2026,
author = {Pinton, Philippe},
title = {Translational Constraints and Next‐Generation Design of IL ‐6 Pathway Biologics in Inflammatory Bowel Disease},
journal = {Clinical and Translational Science},
year = {2026},
volume = {19},
number = {11},
doi = {10.1111/cts.70782}
}
EUVIMED